Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Impulsivity is related to striatal dopamine transporter availability in healthy males.

Costa A, la Fougère C, Pogarell O, Möller HJ, Riedel M, Ettinger U.

Psychiatry Res. 2013 Mar 30;211(3):251-6. doi: 10.1016/j.pscychresns.2012.07.011. Epub 2012 Nov 13.

PMID:
23158972
2.

Low dopamine transporter occupancy by methylphenidate as a possible reason for reduced treatment effectiveness in ADHD patients with cocaine dependence.

Crunelle CL, van den Brink W, Veltman DJ, van Emmerik-van Oortmerssen K, Dom G, Schoevers RA, Booij J.

Eur Neuropsychopharmacol. 2013 Dec;23(12):1714-23. doi: 10.1016/j.euroneuro.2013.05.002. Epub 2013 May 31.

PMID:
23731497
3.

Methylphenidate-evoked changes in striatal dopamine correlate with inattention and impulsivity in adolescents with attention deficit hyperactivity disorder.

Rosa-Neto P, Lou HC, Cumming P, Pryds O, Karrebaek H, Lunding J, Gjedde A.

Neuroimage. 2005 Apr 15;25(3):868-76.

PMID:
15808987
4.

Attention deficit hyperactivity disorder: binding of [99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment.

Dresel S, Krause J, Krause KH, LaFougere C, Brinkbäumer K, Kung HF, Hahn K, Tatsch K.

Eur J Nucl Med. 2000 Oct;27(10):1518-24.

PMID:
11083541
5.

Methylphenidate DAT binding in adolescents with Attention-Deficit/ Hyperactivity Disorder comorbid with Substance Use Disorder--a single photon emission computed tomography with [Tc(99m)]TRODAT-1 study.

Szobot CM, Shih MC, Schaefer T, Júnior N, Hoexter MQ, Fu YK, Pechansky F, Bressan RA, Rohde LA.

Neuroimage. 2008 Apr 15;40(3):1195-201. doi: 10.1016/j.neuroimage.2007.12.050. Epub 2008 Jan 10.

PMID:
18282769
6.

Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit/hyperactivity disorder.

Volkow ND, Wang GJ, Newcorn J, Telang F, Solanto MV, Fowler JS, Logan J, Ma Y, Schulz K, Pradhan K, Wong C, Swanson JM.

Arch Gen Psychiatry. 2007 Aug;64(8):932-40.

PMID:
17679638
7.

Impulsivity in adolescents with bipolar disorder and/or attention-deficit/hyperactivity disorder and healthy controls as measured by the Barratt Impulsiveness Scale.

Nandagopal JJ, Fleck DE, Adler CM, Mills NP, Strakowski SM, DelBello MP.

J Child Adolesc Psychopharmacol. 2011 Oct;21(5):465-8. doi: 10.1089/cap.2010.0096.

8.

Dopamine transporter imaging in adult patients with attention-deficit/hyperactivity disorder.

Hesse S, Ballaschke O, Barthel H, Sabri O.

Psychiatry Res. 2009 Feb 28;171(2):120-8. doi: 10.1016/j.pscychresns.2008.01.002. Epub 2009 Jan 26.

PMID:
19176281
9.

Influence of striatal dopamine transporter availability on the response to methylphenidate in adult patients with ADHD.

Krause J, la Fougere C, Krause KH, Ackenheil M, Dresel SH.

Eur Arch Psychiatry Clin Neurosci. 2005 Dec;255(6):428-31. Epub 2005 Aug 17.

PMID:
16091862
10.

Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients.

Erro R, Pappatà S, Amboni M, Vicidomini C, Longo K, Santangelo G, Picillo M, Vitale C, Moccia M, Giordano F, Brunetti A, Pellecchia MT, Salvatore M, Barone P.

Parkinsonism Relat Disord. 2012 Nov;18(9):1034-8. doi: 10.1016/j.parkreldis.2012.05.022. Epub 2012 Jul 11.

PMID:
22789824
11.

Limbic striatal dopamine D2/3 receptor availability is associated with non-planning impulsivity in healthy adults after exclusion of potential dissimulators.

Reeves SJ, Polling C, Stokes PR, Lappin JM, Shotbolt PP, Mehta MA, Howes OD, Egerton A.

Psychiatry Res. 2012 Apr 30;202(1):60-4. doi: 10.1016/j.pscychresns.2011.09.011. Epub 2012 May 15.

PMID:
22595510
12.

Striatal dopamine transporter density in drug naive patients with attention-deficit/hyperactivity disorder.

Larisch R, Sitte W, Antke C, Nikolaus S, Franz M, Tress W, Müller HW.

Nucl Med Commun. 2006 Mar;27(3):267-70.

PMID:
16479247
13.

Quantitation of dopamine transporter blockade by methylphenidate: first in vivo investigation using [123I]FP-CIT and a dedicated small animal SPECT.

Nikolaus S, Wirrwar A, Antke C, Arkian S, Schramm N, Müller HW, Larisch R.

Eur J Nucl Med Mol Imaging. 2005 Mar;32(3):308-13. Epub 2004 Oct 12.

PMID:
15791440
14.

Attention deficit/hyperactivity disorder: is there a correlation between dopamine transporter density and cerebral blood flow?

da Silva N Jr, Szobot CM, Anselmi CE, Jackowski AP, Chi SM, Hoexter MQ, Anselmi OE, Pechansky F, Bressan RA, Rohde LA.

Clin Nucl Med. 2011 Aug;36(8):656-60. doi: 10.1097/RLU.0b013e318219b49d.

PMID:
21716015
15.

Relationship between SLC6A3 genotype and striatal dopamine transporter availability: a meta-analysis of human single photon emission computed tomography studies.

Costa A, Riedel M, Müller U, Möller HJ, Ettinger U.

Synapse. 2011 Oct;65(10):998-1005. doi: 10.1002/syn.20927. Epub 2011 Mar 28. Review.

PMID:
21404331
16.
17.

Striatal dopamine transporter availability and DAT-1 gene in adults with ADHD: no higher DAT availability in patients with homozygosity for the 10-repeat allele.

Krause J, Dresel SH, Krause KH, La Fougère C, Zill P, Ackenheil M.

World J Biol Psychiatry. 2006;7(3):152-7.

PMID:
16861140
19.

Searching for a neurobiological basis for self-medication theory in ADHD comorbid with substance use disorders: an in vivo study of dopamine transporters using (99m)Tc-TRODAT-1 SPECT.

Silva N Jr, Szobot CM, Shih MC, Hoexter MQ, Anselmi CE, Pechansky F, Bressan RA, Rohde LA.

Clin Nucl Med. 2014 Feb;39(2):e129-34. doi: 10.1097/RLU.0b013e31829f9119.

PMID:
23856832
20.

Striatal dopamine transporter imaging correlates with depressive symptoms and tower of London task performance in Parkinson's disease.

Rektorova I, Srovnalova H, Kubikova R, Prasek J.

Mov Disord. 2008 Aug 15;23(11):1580-7. doi: 10.1002/mds.22158.

PMID:
18618663
Items per page

Supplemental Content

Write to the Help Desk